Hepatitis C Information - Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership

Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership
Genetic Engineering News - Inovio Biomedical Corporation (AMEX:INO), a late stage developer of cancer and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has signed an agreement with Swedish-based Tripep AB (The Stockholm

GlobeImmune raises $38M
Denver Business Journal - The Aurora company, a maker of immunotherapy pharmaceuticals called Tarmogens, will use the funding to complete more placebo-controlled clinical trials for its products, GI-4000 and GI-5005. New investors joining the Series B round include PAC-LINK

FDA Approvals: RPS Adeno Detector, Elecsys NT-proBNP Test, TBA Assay
Medscape News - Jan. 6, 2006 The US Food and Drug Administration (FDA) approved in 2005 a rapid point-of-care test for adenovirus in tear fluid as an aid in the differential diagnosis of acute conjunctivitis; a new indication for an N-terminal pro brain

Hepatitis C treatment difficult in older patients
New Kerala - NEW YORK: Because of side effects, patients over the age of 60 with hepatitis C find it more difficult to stick with standard treatments than do their younger counterparts, according to a study in Japan. Impaired heart, lung and kidney function can